These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36982163)

  • 1. Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore Profiles.
    Bieberich AA; Asquith CRM
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Recognition of FDA-Approved Small Molecule Protein Kinase Drugs in Protein Kinases.
    Zhu Y; Hu X
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
    Asquith CRM; Laitinen T; Bennett JM; Wells CI; Elkins JM; Zuercher WJ; Tizzard GJ; Poso A
    ChemMedChem; 2020 Jan; 15(1):26-49. PubMed ID: 31675459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting protein targets for drug-like compounds using transcriptomics.
    Pabon NA; Xia Y; Estabrooks SK; Ye Z; Herbrand AK; Süß E; Biondi RM; Assimon VA; Gestwicki JE; Brodsky JL; Camacho CJ; Bar-Joseph Z
    PLoS Comput Biol; 2018 Dec; 14(12):e1006651. PubMed ID: 30532261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating Inhibitors of Closely Related Protein Kinases with Single- or Multi-Target Activity via Explainable Machine Learning and Feature Analysis.
    Feldmann C; Bajorath J
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Structure-Activity Relationship Modeling of Kinase Selectivity Profiles.
    Kothiwale S; Borza C; Pozzi A; Meiler J
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28925954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
    Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
    J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
    Martin E; Mukherjee P
    J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Exploration of Chirality for Improved Druggability within the Human Kinome.
    Saha D; Kharbanda A; Yan W; Lakkaniga NR; Frett B; Li HY
    J Med Chem; 2020 Jan; 63(2):441-469. PubMed ID: 31550151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
    Miljković F; Bajorath J
    J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases.
    Akaki T; Bessho Y; Ito T; Fujioka S; Ubukata M; Mori G; Yamanaka K; Orita T; Doi S; Iwanaga T; Ikegashira K; Hantani Y; Nakanishi I; Adachi T
    Bioorg Med Chem; 2021 Aug; 44():116283. PubMed ID: 34274549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling.
    Zhang H; He F; Gao G; Lu S; Wei Q; Hu H; Wu Z; Fang M; Wang X
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
    Bamborough P; Drewry D; Harper G; Smith GK; Schneider K
    J Med Chem; 2008 Dec; 51(24):7898-914. PubMed ID: 19035792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Discovery Maps, a Machine Learning Model That Visualizes and Predicts Kinome-Inhibitor Interaction Landscapes.
    Janssen APA; Grimm SH; Wijdeven RHM; Lenselink EB; Neefjes J; van Boeckel CAA; van Westen GJP; van der Stelt M
    J Chem Inf Model; 2019 Mar; 59(3):1221-1229. PubMed ID: 30372617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase Inhibitors.
    Puhl-Rubio AC; Stashko MA; Wang H; Hardy PB; Tyagi V; Li B; Wang X; Kireev D; Jessen HJ; Frye SV; Shears SB; Pearce KH
    SLAS Discov; 2018 Oct; 23(9):982-988. PubMed ID: 29842835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
    Ravikumar B; Timonen S; Alam Z; Parri E; Wennerberg K; Aittokallio T
    Cell Chem Biol; 2019 Nov; 26(11):1608-1622.e6. PubMed ID: 31521622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues.
    Xiao Y; Guo L; Wang Y
    Mol Cell Proteomics; 2014 Apr; 13(4):1065-75. PubMed ID: 24520089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in kinase drug discovery: targets, indications and inhibitor design.
    Attwood MM; Fabbro D; Sokolov AV; Knapp S; Schiöth HB
    Nat Rev Drug Discov; 2021 Nov; 20(11):839-861. PubMed ID: 34354255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.